Your browser doesn't support javascript.
loading
Serum immunoglobulin G antibody titer to Fusobacterium nucleatum is associated with unfavorable outcome after stroke.
Nishi, H; Hosomi, N; Ohta, K; Aoki, S; Nakamori, M; Nezu, T; Shigeishi, H; Shintani, T; Obayashi, T; Ishikawa, K; Kinoshita, N; Shiga, Y; Sugiyama, M; Ohge, H; Maruyama, H; Kawaguchi, H; Kurihara, H.
Affiliation
  • Nishi H; Department of General Dentistry, Hiroshima University Hospital, Hiroshima, Japan.
  • Hosomi N; Department of Neurology, Chikamori Hospital, Kochi, Japan.
  • Ohta K; Department of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Aoki S; Department of Public Oral Health, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Nakamori M; Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Nezu T; Department of Neurology, Suiseikai Kajikawa Hospital, Hiroshima, Japan.
  • Shigeishi H; Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Shintani T; Department of Public Oral Health, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Obayashi T; Center of Oral Examination, Hiroshima University Hospital, Hiroshima, Japan.
  • Ishikawa K; Department of General Dentistry, Hiroshima University Hospital, Hiroshima, Japan.
  • Kinoshita N; Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Shiga Y; Department of Neurology, Suiseikai Kajikawa Hospital, Hiroshima, Japan.
  • Sugiyama M; Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Ohge H; Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Maruyama H; Department of Public Oral Health, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Kawaguchi H; Department of Infectious Diseases, Hiroshima University Hospital, Hiroshima, Japan.
  • Kurihara H; Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Clin Exp Immunol ; 200(3): 302-309, 2020 06.
Article in En | MEDLINE | ID: mdl-32155293
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Fusobacterium nucleatum / Stroke / Antibodies, Bacterial Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Exp Immunol Year: 2020 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Fusobacterium nucleatum / Stroke / Antibodies, Bacterial Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Exp Immunol Year: 2020 Type: Article Affiliation country: Japan